What is the recommended treatment regimen, dosing, and duration for an Enterococcus infection?

Treatment of Enterococcal Infections

For susceptible enterococcal infections, ampicillin or penicillin combined with gentamicin remains the gold standard, with treatment duration of 4-6 weeks for endocarditis and 7-14 days for uncomplicated bloodstream infections after catheter removal. 1

Treatment Regimens by Infection Type

Endocarditis (Native Valve)

For penicillin and aminoglycoside-susceptible strains:

• Ampicillin 12 g/day IV in divided doses (or penicillin G 18-30 million units/day) PLUS gentamicin 3 mg/kg/day in 2-3 divided doses 1
• Duration: 4 weeks if symptoms <3 months; 6 weeks if symptoms ≥3 months 1
• Gentamicin must be given in multiple divided doses (every 8 hours), NOT once daily, for enterococcal infections - this is critical as once-daily dosing is less effective against enterococci 1, 2, 3
• Target gentamicin peak: ~3 μg/mL; trough: <1 μg/mL 1

For aminoglycoside-resistant strains:

• Ampicillin 2 g IV every 4 hours PLUS ceftriaxone 2 g IV every 12 hours for 6 weeks 1
• This double β-lactam regimen avoids aminoglycoside toxicity and is equally effective 1

Endocarditis (Prosthetic Valve)

• Minimum 6 weeks of therapy required for all prosthetic valve infections 1
• Same drug combinations as native valve, but extended duration 1

Vancomycin-Resistant Enterococcus (VRE)

For VRE bacteremia:

• Linezolid 600 mg IV/PO every 12 hours (strong recommendation) 1
• Alternative: High-dose daptomycin 8-12 mg/kg/day IV, potentially combined with β-lactams (penicillins, cephalosporins, or carbapenems) 1

For VRE intra-abdominal infections:

• Tigecycline 100 mg IV loading dose, then 50 mg IV every 12 hours 1

For VRE uncomplicated urinary tract infections:

• Fosfomycin 3 g PO single dose 1
• Alternative: Nitrofurantoin 100 mg PO every 6 hours 1
• Alternative: High-dose ampicillin 18-30 g IV daily in divided doses (if susceptible) 1

Catheter-Related Bloodstream Infections (CRBSI)

Management approach:

• Remove short-term catheters immediately 1
• Remove long-term catheters if: insertion site infection, suppurative thrombophlebitis, sepsis, endocarditis, persistent bacteremia >72 hours, or metastatic infection 1

Antibiotic therapy:

• Ampicillin is preferred for ampicillin-susceptible enterococci; vancomycin for ampicillin-resistant strains 1
• Duration: 7-14 days for uncomplicated CRBSI after catheter removal 1
• A 7-day course appears safe for non-complicated enterococcal CRBSI when the catheter is removed 4
• If catheter retained: use antibiotic lock therapy plus systemic antibiotics 1

Endocarditis evaluation required if:

• New murmur or embolic phenomena 1
• Persistent bacteremia/fever >72 hours despite appropriate therapy 1
• Prosthetic valve or endovascular foreign body present 1

Intra-Abdominal Infections

Empiric anti-enterococcal therapy indicated for:

• Health care-associated infections 1
• Postoperative infections 1
• Patients previously receiving cephalosporins or other agents selecting for Enterococcus 1
• Immunocompromised patients 1
• Patients with valvular heart disease or prosthetic intravascular materials 1

Antibiotic selection:

• Target Enterococcus faecalis empirically 1
• Options: ampicillin, piperacillin-tazobactam, or vancomycin based on susceptibility 1
• Do NOT empirically cover vancomycin-resistant E. faecium unless patient is at very high risk (e.g., liver transplant with hepatobiliary source, known VRE colonization) 1

Critical Dosing Considerations

Aminoglycoside Administration

The dosing interval for gentamicin is fundamentally different for enterococcal infections compared to other bacterial infections:

• Multiple daily divided doses (every 8 hours) are required - once-daily dosing is LESS effective 1, 2, 3
• This differs from other infections where once-daily aminoglycoside dosing is standard 1
• Prolonged aminoglycoside serum levels appear necessary for optimal synergy with cell-wall active agents 2

Monitoring Requirements

• Weekly monitoring of vancomycin and gentamicin levels plus renal function tests when using multiple nephrotoxic agents 1
• Adjust doses based on renal function 1

Special Populations

β-Lactam Intolerant Patients

For endocarditis when β-lactams cannot be used:

• Vancomycin 30 mg/kg/day IV in 2 divided doses PLUS gentamicin 1
• Duration: 6 weeks for native valve, minimum 6 weeks for prosthetic valve 1
• Note: Vancomycin-gentamicin is less active than penicillin/ampicillin-gentamicin combinations and carries higher nephrotoxicity/ototoxicity risk 1

Renal Impairment

For patients unable to tolerate full aminoglycoside course:

• Consider streptomycin instead of gentamicin (less nephrotoxic but more ototoxic) 1
• Avoid streptomycin if creatinine clearance <50 mL/min 1
• Consider double β-lactam regimen (ampicillin-ceftriaxone) to avoid aminoglycosides entirely 1

Common Pitfalls

Critical errors to avoid:

• Using once-daily gentamicin dosing for enterococcal infections (ineffective) 1, 2, 3
• Treating enterococci with cephalosporins alone (enterococci are intrinsically resistant) 1
• Inadequate treatment duration (<4 weeks for native valve endocarditis with prolonged symptoms) 1
• Failing to remove infected catheters in complicated CRBSI 1
• Not performing TEE when enterococcal bacteremia persists >72 hours 1

Infectious Disease Consultation

Infectious disease consultation is strongly recommended for:

• All enterococcal endocarditis cases 1
• Vancomycin-resistant enterococcal infections 1
• Aminoglycoside-resistant strains requiring alternative regimens 1
• ID consultation is independently associated with reduced mortality in enterococcal bacteremia 5